Fondren Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-100,000
| Closed | -$221K | – | 40 |
|
|
2020
Q1 | $221K | Sell |
100,000
-293,000
| -75% | -$648K | 0.56% | 45 |
|
|
2019
Q4 | $1.2M | Sell |
393,000
-472,000
| -55% | -$1.44M | 1.23% | 25 |
|
|
2019
Q3 | $2.66M | Buy |
865,000
+406,072
| +88% | +$1.25M | 2.21% | 13 |
|
|
2019
Q2 | $918K | Buy |
458,928
+308,928
| +206% | +$618K | 0.87% | 34 |
|
|
2019
Q1 | $647K | Buy |
+150,000
| New | +$647K | 0.52% | 43 |
|
|
2017
Q1 | – | Sell |
-230,000
| Closed | -$702K | – | 44 |
|
|
2016
Q4 | $702K | Buy |
+230,000
| New | +$702K | 0.5% | 41 |
|